Holen Sie sich die Stockscreener-App
4.02
1.23%
-0.05
Handel nachbörslich:
4.08
0.06
+1.49%
Capsovision Inc Aktie (CV) Neueste Nachrichten
CapsoVision Reports Second Quarter 2025 Financial Results - GlobeNewswire
CapsoVision (NASDAQ:CV) versus ReShape Lifesciences (OTCMKTS:RSLSD) Head to Head Comparison - Defense World
Reviewing ReShape Lifesciences (OTCMKTS:RSLSD) and CapsoVision (NASDAQ:CV) - Defense World
CapsoVision, Inc.'s Quiet Period Set To Expire on August 11th (NASDAQ:CV) - MarketBeat
CapsoVision, Inc.’s (NASDAQ:CV) Quiet Period Will End on August 11th - Defense World
Is capsovision scam - AInvest
Roth Capital Predicts CapsoVision's Q2 Earnings (NASDAQ:CV) - MarketBeat
CapsoVision (NASDAQ:CV) Raised to Strong-Buy at Roth Capital - MarketBeat
CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - GlobeNewswire
Capsovision, Inc. shares fall 2.19% intraday as Kioxia Corporation announces new UFS 4.1 devices for automotive applications. - AInvest
Q2 Earnings Estimate for CapsoVision Issued By Roth Capital - Defense World
Roth Capital Upgrades CapsoVision (NASDAQ:CV) to Strong-Buy - Defense World
CapsoVision (NASDAQ:CV) Rating Increased to Strong-Buy at Roth Capital - Defense World
CapsoVision (NASDAQ:CV) Upgraded at Roth Capital - Defense World
CapsoVision (NASDAQ:CV) Upgraded by Roth Capital to Strong-Buy Rating - Defense World
CapsoVision (NASDAQ:CV) Raised to “Strong-Buy” at Roth Capital - Defense World
Capsovision, Inc. shares rise 3.45% intraday after Canon Inc. announces share buyback plan. - AInvest
CapsoVision is a buy, this analyst says - Cantech Letter
Capsovision, Inc. shares fall 1.15% premarket after Canon Inc. announced a buyback plan. - AInvest
CapsoVision (NASDAQ:CV) Now Covered by Benchmark - Defense World
CapsoVision (NASDAQ:CV) Earns Speculative Buy Rating from Analysts at Benchmark - MarketBeat
Benchmark Co. Initiates CapsoVision(CV.US) With Buy Rating, Announces Target Price $5 - 富途牛牛
CapsoVision: Benchmark initiates coverage with Speculative Buy rating, $5 price target. - AInvest
CapsoVision stock initiated with Speculative Buy rating at Benchmark By Investing.com - Investing.com India
Benchmark starts CapsoVision with a Speculative Buy as CapsoCam Plus takes share - TipRanks
CapsoVision initiated with a Buy at Roth Capital - TipRanks
CapsoVision stock initiated with Buy rating at Roth/MKM on GI imaging potential - Investing.com Nigeria
CapsoVision Completes $27.5 Million Nasdaq IPO - Global Legal Chronicle
CapsoVision enters development agreement with Canon and announces partial IPO overallotment exercise - Investing.com India
CapsoVision Raises $600,000 Through IPO Overallotment - TipRanks
Capsovision, Inc IPOs Tomorrow, Here's What You Need To Know - 富途牛牛
Capsovision, Inc. shares fall 2.66% after-hours following IPO close. - AInvest
CapsoVision prices $27.5M IPO - MSN
Capsovision, Inc. shares rise 5.25% intraday after closing $27.5 million IPO. - AInvest
Why Did CapsoVision Plunge 10.45% After IPO Pricing? - AInvest
CapsoVision's IPO: A Pill to Swallow in the GI Diagnostics Market? - AInvest
CapsoVision Soars 40.31% on IPO Debut - AInvest
CapsoVision Closes $27.5 Million IPO; Shares Rebound - MarketScreener
CapsoVision, Inc. Successfully Closes Initial Public Offering Raising $27.5 Million - Nasdaq
CapsoVision Announces Closing of Initial Public Offering - GlobeNewswire
CapsoVision Stocks: Bursting Bubbles or Rising Stars? - StocksToTrade
CapsoVision’s Wild Ride: Why This Med-Tech Newcomer Is Turning Heads on Nasdaq - RagingBull
CapsoVision’s Rollercoaster: Risk or Reward? - timothysykes.com
CapsoVision, Inc.(NasdaqCM: CV) added to NASDAQ Composite Index - MarketScreener
CapsoVision begins trading on Nasdaq at $5 per share, declines since - Investing.com India
CV IPO NewsMedical device maker CapsoVision prices IPO at $5, the low end of the range - renaissancecapital.com
CapsoVision Prices 5.5M Share IPO at $5/sh - Investing.com Australia
CapsoVision Prices 5.5M Share IPO at $5/sh By Investing.com - Investing.com Canada
2.30%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):